# Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.

> **NCT01759212** · PHASE2,PHASE3 · TERMINATED · sponsor: **AHEPA University Hospital** · enrollment: 1 (actual)

## Conditions studied

- Heart Failure
- Ischemic Cardiomyopathy

## Interventions

- **BIOLOGICAL:** Allogeneic stem cells implantation

## Key facts

- **NCT ID:** NCT01759212
- **Lead sponsor:** AHEPA University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of eligible patients
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01759212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01759212, "Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01759212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*